Glucose-6-phosphatase inhibitors for the treatment of Type 2 diabetes

Expert Opinion on Therapeutic Patents

Volumn 11, Issue 9, 2001, Pages 1429-1441

  Madsen, P ^a   Westergaard, N ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

cell; Blood glucose homeostasis; EC 3.1.3.9; Glucose 6 phosphatase; Inhibitors; T1 translocase; Type 2 diabetes

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CARBOHYDRATE; CARBON; CARRIER PROTEIN; DEOXYGLUCOSE; DIHYDROXYACETONE PHOSPHATE; ENZYME INHIBITOR; FRUCTOSE 1 PHOSPHATE; FRUCTOSE BISPHOSPHATASE; GLUCAGON; GLUCOKINASE; GLUCOSAMINE DERIVATIVE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER; GLUTAMINE; GLYCOGEN; INSULIN; LIVER ENZYME; MESSENGER RNA; N ACETYLGLUCOSAMINE; NEW DRUG; PROTEIN INHIBITOR; PYROPHOSPHATE; S 3483; STREPTOZOCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANADIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; CATALYSIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME MECHANISM; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLYCOGENOLYSIS; HUMAN; LIVER METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATENT; PUBLICATION; RAT; REVIEW; STRUCTURE ANALYSIS;

EID: 0034877151     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.11.9.1429     Document Type: Review

References (80)

1. Mechanisms of blood glucose homeostasis
2. Role of liver and muscle in Type II diabetes
3. Autoregulation of hepatic glucose-production
4. Role of liver in pathophysiology of NIDDM
5. Hepatic glucose production in insulin-resistant states
6. Pathogenesis of NIDDM: A balanced overview
7. Multifunctional glucose-6-phosphatase: A critical review
8. The molecular basis of the hepatic microsomal glucose-6-phosphatase system
9. Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats
10. Regulation of glucose production by the liver
11. The molecular basis of the type 1 glycogen storage diseases
12. Glycogen storage disease
13. Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level
14. Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states
15. Rat hepatic microsomal glucose-6-phosphatase protein levels are increased in streptozotocin-induced diabetes
16. Regulation of the hepatic microsomal glucose-6-phosphatase enzyme
17. Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes
18. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats
19. The effects of starvation and alloxan-diabetes on the contents of citrate and other metabolic intermediates in rat liver
20. Nuclear magnetic resonance studies of hepatic glucose metabolism in humans
21. The pancreatic beta-cell glucose sensor
22. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm
23. The microsomal glucose-6-phosphatase enzyme of pancreatic islets
24. Glucose cycling is markedly enhanced in pancreatic islets of obese hyperglycemic mice
25. Glucose cycling in islets from healthy and diabetic rats
26. Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone
27. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat
28. Adenovirus-mediated expression of the catalytic subunit of glucose-6-phosphatase in ins-1 cells - Effects on glucose cycling, glucose usage, and insulin-secretion
29. Stable overexpression of the glucose-6-phosphatase catalytic subunit attenuates glucose sensitivity of insulin secretion from a mouse pancreatic β-cell line
30. Effects of 3-mercaptopicolinic acid and a derivative of chlorogenic acid (S-3483) on hepatic and islet glucose-6-phosphatase activity
31. Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein
32. Glucose-6-phosphatase: Two concepts of membrane function relationship
33. Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase
34. Overexpression of the P46 (T1) translocase component of the glucose-6-phosphatase complex in hepatocytes impairs glycogen accumulation via hydrolysis of glucose 1-phosphate
35. Modification of hydrolytic and synthetic activities of liver microsomal glucose 6-phosphatase
36. Metabolic intermediates as potential regulators of glucose-6-phosphatase
37. Regulation of gluconeogenesis by glycerol and its phosphorylated derivatives
38. 7-Carbon mimics of D-glucose and L-fucose: Activation by 6R-, and inactivation by 6S, 6C-methylglucose of glycogen synthase: Inhibition of glucokinase and/or glucose-6-phosphatase
39. Tungstate: A potent inhibitor of multifunctional glucose-6-phosphatase
40. Tungstate: A potent inhibitor of multifunctional glucose-6-phosphatase
41. Tungstate is an effective antidiabetic agent in Streptozotocin-induced diabetic rats: A long-term study
42. Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo
43. Vanadate: A potent inhibitor of multifunctional glucose-6-phosphatase
44. Glucose-6-phosphatase catalytic enzyme inhibitors: Synthesis and In vitro evaluation of novel 4,5,6-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines
45. Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein
46. Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein
47. N,N-Dibenzyl-N-benzylidenehydrazines: Potent competitive glucose-6-phosphatase catalytic enzyme inhibitors
48. Characteristics and specificity of the inhibition of liver glucose-6-phosphatase by arachidonic acid: Lesser inhibitability of the enzyme of diabetic rats
49. Fatty acyl-CoA esters inhibit glucose-6-phosphatase in rat liver microsomes
50. Mechanisms by which fatty-acyl-CoA esters inhibit or activate glucose-6-phosphatase in intact and detergent-treated rat liver microsomes
51. Differential effects of palmitoyl coenzyme-A on liver microsomal inorganic pyrophosphate-glucose phosphotransferase and glucose-6-phosphate phosphohydrolase
52. Stabilization of partially-purified glucose-6-phosphatase by fluoride
53. Identification of a liver microsomal glucose-6-phosphatase
54. Aluminum ions are required for stabilization and inhibition of hepatic microsomal glucose-6-phosphatase by sodium fluoride
55. Image analysis for histochemical study of glucose-6-phosphatase inactivation by diethyl pyrocarbonate in normal human liver
56. Inhibition of glucose-6-phosphate phosphohydrolase by 3-mercaptopicolinate and two analogs is metabolically directive
57. Time-dependent inhibition of glucose 6-phosphatase by 3-mercaptopicolinic acid
58. A convenient preparation of 3-mercaptopicolinic Acid
59. Synthesis and preliminary SAR of new inhibitors of hepatic glucose-6-phosphate translocase
60. Identification of two new inhibitors of the hepatic glucose-6-phosphatase system
61. Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose 6-phosphatase
62. Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose-6-phosphatase
63. Chlorogenic acid and synthetic chlorogenic acid derivatives: Novel inhibitors of hepatic glucose-6-phosphate translocase
64. Chlorogenic acid analogue S 3483: A potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems
65. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system
66. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system
67. Upregulation of hepatic glucose 6-phosphatase gene expression in rats treated with an inhibitor of glucose-6-phosphate translocase
68. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phoisphate translocase
69. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats
70. Direct evidence for the involvement of two Glucose 6-phosphate-binding sites in the glucose-6-phosphatase activity of intact liver microsomes. Characterization of T1, the microsomal glucose-6-phosphate transport binding assay
71. Identification of protein components of the microsomal glucose 6-phosphate transporter by photoaffinity labelling
72. Pharmacological interference with hepatic glucose production
73. Kodaistatins, novel inhibitors of glucose-6-phosphate translocase T1 from Aspergillus terreus Thom DSM 11247. Isolation and structural elucidation
74. Kodaistatin A, a new inhibitor from aspergillus terreus of the hepatic glucose-6-phosphatase system
75. The chemical structure of mumbaistatin, a novel glucose-6-phosphatase translocase inhibitor produced by streptomyces sp DSM 11641
76. Glucose release by the liver under conditions of reduced activity of glucose-6-phosphatase
77. Effects of stevia rebaudiana natural products on rat liver mitochondria
78. Inhibition of hepatic neoglycogenesis and glucose-6-phosphatase by aqueous extract of Bauhinia megalandra leaves
79. Inhibition of the glucose-6-phosphatase system by N-bromoacetylethanolamine phosphate, a potential affinity label for auxiliary proteins
80. N-bromoacetylethanolamine phosphate as a probe for the identification of a liver microsomal glucose-6-phosphate transporter peptide in rats and ehrlich ascites tumor-bearing mice